Enalapril versus Triple-Drug Therapy in the Treatment of Renovascular Hypertension
- 1 January 1985
- journal article
- clinical trial
- Published by Springer Nature in Drugs
- Vol. 30 (Supplement) , 59-69
- https://doi.org/10.2165/00003495-198500301-00009
Abstract
18 renovascular hypertensive patients were entered into a randomised, double-blind protocol to assess the safety and efficacy of enalapril (5 to 20mg twice-daily) and hydrochlorothiazide (50 to 100...Keywords
This publication has 16 references indexed in Scilit:
- Regulation of renal hemodynamics and glomerular filtration in patients with renovascular hypertension during converting enzyme inhibition with captoprilThe American Journal of Medicine, 1984
- Mechanism of deterioration in renal function in patients with renovascular hypertension treated with enalapril.Hypertension, 1984
- Captopril and Renal AutoregulationNew England Journal of Medicine, 1983
- Inhibition of Angiotensin-Converting Enzyme in Renal-Transplant Recipients with HypertensionNew England Journal of Medicine, 1983
- Captopril-Induced Functional Renal Insufficiency in Patients with Bilateral Renal-Artery Stenoses or Renal-Artery Stenosis in a Solitary KidneyNew England Journal of Medicine, 1983
- Repeated renal failure with use of captopril in a cystinotic renal allograft recipient.BMJ, 1983
- Comparison of the hormonal and renal effects of captopril in severe essential and renovascular hypertensionThe American Journal of Cardiology, 1982
- Minoxidil in Refractory HypertensionJournal of Cardiovascular Pharmacology, 1980
- Treatment of Refractory Hypertension with MinoxidilJournal of Cardiovascular Pharmacology, 1980
- Reversible renal failure during treatment with captopril.BMJ, 1979